Send mail to Author

Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes : rationale and design of the ODYSSEY Outcomes trial (Article)

Please indicate your contact information and select, which author you want to contact.



 
 _____       ___      _  __     ___      _____    __   __  
|  __ \\    / _ \\   | |/ //   / _ \\   /  ___||  \ \\/ // 
| |  \ ||  / //\ \\  | ' //   / //\ \\ | // __     \ ` //  
| |__/ || |  ___  || | . \\  |  ___  ||| \\_\ ||    | ||   
|_____//  |_||  |_|| |_|\_\\ |_||  |_|| \____//     |_||   
 -----`   `-`   `-`  `-` --` `-`   `-`   `---`      `-`'
 


Back to frontdoor view

OPUS4 Logo